Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for RCOR1_MTA3
Z-value: 0.20
Motif logo
Transcription factors associated with RCOR1_MTA3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RCOR1
|
ENSG00000089902.8 | REST corepressor 1 |
|
MTA3
|
ENSG00000057935.9 | metastasis associated 1 family member 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RCOR1 | hg19_v2_chr14_+_103058948_103059005 | -0.37 | 3.7e-02 | Click! |
| MTA3 | hg19_v2_chr2_+_42721689_42721723 | 0.22 | 2.2e-01 | Click! |
Activity profile of RCOR1_MTA3 motif
Sorted Z-values of RCOR1_MTA3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_233792837 | 8.08 |
ENST00000373552.4
ENST00000409079.1 |
NGEF
|
neuronal guanine nucleotide exchange factor |
| chr1_-_20812690 | 7.61 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr19_-_51017881 | 7.59 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
| chr4_-_77819002 | 7.01 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
| chr16_+_56691911 | 6.84 |
ENST00000568475.1
|
MT1F
|
metallothionein 1F |
| chr1_-_21995794 | 6.81 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr2_+_39893043 | 6.63 |
ENST00000281961.2
|
TMEM178A
|
transmembrane protein 178A |
| chr11_+_27062272 | 6.53 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr22_-_37213045 | 6.39 |
ENST00000406910.2
ENST00000417718.2 |
PVALB
|
parvalbumin |
| chr19_+_45409011 | 6.29 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr16_+_8768422 | 6.27 |
ENST00000268251.8
ENST00000564714.1 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr2_-_20425158 | 6.02 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
| chr9_+_80912059 | 5.89 |
ENST00000347159.2
ENST00000376588.3 |
PSAT1
|
phosphoserine aminotransferase 1 |
| chr1_-_21948906 | 5.86 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr16_+_56691606 | 5.81 |
ENST00000334350.6
|
MT1F
|
metallothionein 1F |
| chr16_+_56666563 | 5.79 |
ENST00000570233.1
|
MT1M
|
metallothionein 1M |
| chr16_+_56703703 | 5.76 |
ENST00000332374.4
|
MT1H
|
metallothionein 1H |
| chr2_+_105471969 | 5.71 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr2_-_46385 | 5.59 |
ENST00000327669.4
|
FAM110C
|
family with sequence similarity 110, member C |
| chr2_+_95691445 | 5.57 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
| chr9_-_97402413 | 5.50 |
ENST00000414122.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr10_-_123357598 | 5.42 |
ENST00000358487.5
ENST00000369058.3 ENST00000369060.4 ENST00000359354.2 |
FGFR2
|
fibroblast growth factor receptor 2 |
| chr12_-_103310987 | 5.41 |
ENST00000307000.2
|
PAH
|
phenylalanine hydroxylase |
| chr19_-_51472031 | 5.39 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_+_55795493 | 5.29 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr19_-_33555780 | 5.26 |
ENST00000254260.3
ENST00000400226.4 |
RHPN2
|
rhophilin, Rho GTPase binding protein 2 |
| chr6_+_1312675 | 5.23 |
ENST00000296839.2
|
FOXQ1
|
forkhead box Q1 |
| chr12_-_322504 | 5.22 |
ENST00000424061.2
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
| chr11_-_17565947 | 5.20 |
ENST00000527020.1
ENST00000318024.4 |
USH1C
|
Usher syndrome 1C (autosomal recessive, severe) |
| chr19_-_11591848 | 5.18 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
| chr9_-_6645628 | 5.14 |
ENST00000321612.6
|
GLDC
|
glycine dehydrogenase (decarboxylating) |
| chr11_-_119293903 | 5.13 |
ENST00000580275.1
|
THY1
|
Thy-1 cell surface antigen |
| chr2_+_47596287 | 5.13 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr18_-_658244 | 5.05 |
ENST00000585033.1
ENST00000323813.3 |
C18orf56
|
chromosome 18 open reading frame 56 |
| chr19_-_47975106 | 5.03 |
ENST00000539381.1
ENST00000594353.1 ENST00000542837.1 |
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr19_-_3480540 | 5.00 |
ENST00000215531.4
|
C19orf77
|
chromosome 19 open reading frame 77 |
| chr16_+_56703737 | 4.99 |
ENST00000569155.1
|
MT1H
|
metallothionein 1H |
| chr8_+_54793425 | 4.92 |
ENST00000522225.1
|
RGS20
|
regulator of G-protein signaling 20 |
| chr19_+_4153598 | 4.88 |
ENST00000078445.2
ENST00000252587.3 ENST00000595923.1 ENST00000602257.1 ENST00000602147.1 |
CREB3L3
|
cAMP responsive element binding protein 3-like 3 |
| chr7_-_150038704 | 4.88 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
| chr12_-_323248 | 4.84 |
ENST00000535347.1
ENST00000536824.1 |
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
| chr16_+_56691838 | 4.82 |
ENST00000394501.2
|
MT1F
|
metallothionein 1F |
| chr3_+_105085734 | 4.80 |
ENST00000306107.5
|
ALCAM
|
activated leukocyte cell adhesion molecule |
| chr7_-_95025661 | 4.80 |
ENST00000542556.1
ENST00000265627.5 ENST00000427422.1 ENST00000451904.1 |
PON1
PON3
|
paraoxonase 1 paraoxonase 3 |
| chr5_+_78407602 | 4.79 |
ENST00000274353.5
ENST00000524080.1 |
BHMT
|
betaine--homocysteine S-methyltransferase |
| chr2_-_20424844 | 4.79 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
| chr8_+_120220561 | 4.78 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
| chrX_-_102319092 | 4.76 |
ENST00000372728.3
|
BEX1
|
brain expressed, X-linked 1 |
| chr2_-_220173685 | 4.74 |
ENST00000423636.2
ENST00000442029.1 ENST00000412847.1 |
PTPRN
|
protein tyrosine phosphatase, receptor type, N |
| chr21_-_44496441 | 4.73 |
ENST00000359624.3
ENST00000352178.5 |
CBS
|
cystathionine-beta-synthase |
| chr12_-_6484715 | 4.72 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr10_+_48355024 | 4.70 |
ENST00000395702.2
ENST00000442001.1 ENST00000433077.1 ENST00000436850.1 ENST00000494156.1 ENST00000586537.1 |
ZNF488
|
zinc finger protein 488 |
| chr7_+_149571045 | 4.68 |
ENST00000479613.1
ENST00000606024.1 ENST00000464662.1 ENST00000425642.2 |
ATP6V0E2
|
ATPase, H+ transporting V0 subunit e2 |
| chr11_-_45307817 | 4.66 |
ENST00000020926.3
|
SYT13
|
synaptotagmin XIII |
| chr9_-_97402531 | 4.57 |
ENST00000415431.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr16_-_51185149 | 4.57 |
ENST00000566102.1
ENST00000541611.1 |
SALL1
|
spalt-like transcription factor 1 |
| chr16_+_67465016 | 4.56 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
| chr12_-_323689 | 4.52 |
ENST00000428720.1
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
| chr2_+_95691417 | 4.48 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
| chr2_+_73144604 | 4.45 |
ENST00000258106.6
|
EMX1
|
empty spiracles homeobox 1 |
| chr19_+_35609380 | 4.43 |
ENST00000604621.1
|
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr10_+_102106829 | 4.42 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
| chr3_+_239652 | 4.42 |
ENST00000435603.1
|
CHL1
|
cell adhesion molecule L1-like |
| chr5_+_68788594 | 4.39 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
| chr12_-_6483969 | 4.38 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr19_-_36001286 | 4.34 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr17_+_4675175 | 4.32 |
ENST00000270560.3
|
TM4SF5
|
transmembrane 4 L six family member 5 |
| chr21_-_44495919 | 4.32 |
ENST00000398158.1
|
CBS
|
cystathionine-beta-synthase |
| chr16_+_56685796 | 4.29 |
ENST00000334346.2
ENST00000562399.1 |
MT1B
|
metallothionein 1B |
| chr7_+_24323782 | 4.29 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
| chr1_-_204183071 | 4.28 |
ENST00000308302.3
|
GOLT1A
|
golgi transport 1A |
| chr8_-_133493200 | 4.27 |
ENST00000388996.4
|
KCNQ3
|
potassium voltage-gated channel, KQT-like subfamily, member 3 |
| chr7_+_150498610 | 4.25 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
| chr7_-_99573640 | 4.23 |
ENST00000411734.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr16_+_87636474 | 4.21 |
ENST00000284262.2
|
JPH3
|
junctophilin 3 |
| chr12_-_6484376 | 4.20 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr6_-_3227877 | 4.20 |
ENST00000259818.7
|
TUBB2B
|
tubulin, beta 2B class IIb |
| chr7_-_99573677 | 4.19 |
ENST00000292401.4
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr19_-_7936344 | 4.19 |
ENST00000599142.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
| chr11_-_625163 | 4.18 |
ENST00000349570.7
|
CDHR5
|
cadherin-related family member 5 |
| chr5_-_176056974 | 4.18 |
ENST00000510387.1
ENST00000506696.1 |
SNCB
|
synuclein, beta |
| chr16_-_56701933 | 4.17 |
ENST00000568675.1
ENST00000569500.1 ENST00000444837.2 ENST00000379811.3 |
MT1G
|
metallothionein 1G |
| chr2_-_74669009 | 4.17 |
ENST00000272430.5
|
RTKN
|
rhotekin |
| chr12_-_113574028 | 4.16 |
ENST00000546530.1
ENST00000261729.5 |
RASAL1
|
RAS protein activator like 1 (GAP1 like) |
| chr3_+_133465228 | 4.16 |
ENST00000482271.1
ENST00000264998.3 |
TF
|
transferrin |
| chr19_-_51487282 | 4.15 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
| chr6_+_30852738 | 4.15 |
ENST00000508312.1
ENST00000512336.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr17_-_7164410 | 4.13 |
ENST00000574070.1
|
CLDN7
|
claudin 7 |
| chr11_+_27062502 | 4.11 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr7_-_99569468 | 4.07 |
ENST00000419575.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr19_+_15751689 | 4.07 |
ENST00000586182.2
ENST00000591058.1 ENST00000221307.8 |
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3 |
| chr7_+_150498783 | 4.06 |
ENST00000475536.1
ENST00000468689.1 |
TMEM176A
|
transmembrane protein 176A |
| chr21_-_44497033 | 4.05 |
ENST00000441030.1
|
CBS
|
cystathionine-beta-synthase |
| chr11_+_116700600 | 4.05 |
ENST00000227667.3
|
APOC3
|
apolipoprotein C-III |
| chrX_+_101380642 | 4.04 |
ENST00000372780.1
ENST00000329035.2 |
TCEAL2
|
transcription elongation factor A (SII)-like 2 |
| chr1_+_201979645 | 4.03 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr19_+_496454 | 4.02 |
ENST00000346144.4
ENST00000215637.3 ENST00000382683.4 |
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1 |
| chr19_-_10047219 | 3.99 |
ENST00000264833.4
|
OLFM2
|
olfactomedin 2 |
| chr3_+_111717511 | 3.96 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
| chr1_-_21978312 | 3.96 |
ENST00000359708.4
ENST00000290101.4 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr19_-_51017127 | 3.96 |
ENST00000389208.4
|
ASPDH
|
aspartate dehydrogenase domain containing |
| chr16_-_31147020 | 3.94 |
ENST00000568261.1
ENST00000567797.1 ENST00000317508.6 |
PRSS8
|
protease, serine, 8 |
| chr11_+_27062860 | 3.91 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr1_-_156217829 | 3.91 |
ENST00000356983.2
ENST00000335852.1 ENST00000340183.5 ENST00000540423.1 |
PAQR6
|
progestin and adipoQ receptor family member VI |
| chr1_-_160040038 | 3.91 |
ENST00000368089.3
|
KCNJ10
|
potassium inwardly-rectifying channel, subfamily J, member 10 |
| chr19_-_291365 | 3.90 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr19_+_54412517 | 3.88 |
ENST00000391767.1
|
CACNG7
|
calcium channel, voltage-dependent, gamma subunit 7 |
| chrX_-_101410762 | 3.88 |
ENST00000543160.1
ENST00000333643.3 |
BEX5
|
brain expressed, X-linked 5 |
| chr13_+_96204961 | 3.87 |
ENST00000299339.2
|
CLDN10
|
claudin 10 |
| chr20_-_25062767 | 3.84 |
ENST00000429762.3
ENST00000444511.2 ENST00000376707.3 |
VSX1
|
visual system homeobox 1 |
| chr7_-_100239132 | 3.84 |
ENST00000223051.3
ENST00000431692.1 |
TFR2
|
transferrin receptor 2 |
| chr2_+_231729615 | 3.82 |
ENST00000326427.6
ENST00000335005.6 ENST00000326407.6 |
ITM2C
|
integral membrane protein 2C |
| chr16_-_51185172 | 3.81 |
ENST00000251020.4
|
SALL1
|
spalt-like transcription factor 1 |
| chr9_-_122131696 | 3.80 |
ENST00000373964.2
ENST00000265922.3 |
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1 |
| chr2_+_17721937 | 3.79 |
ENST00000451533.1
|
VSNL1
|
visinin-like 1 |
| chr11_-_14993819 | 3.78 |
ENST00000396372.2
ENST00000361010.3 ENST00000359642.3 ENST00000331587.4 |
CALCA
|
calcitonin-related polypeptide alpha |
| chr11_+_75428857 | 3.77 |
ENST00000198801.5
|
MOGAT2
|
monoacylglycerol O-acyltransferase 2 |
| chr12_-_56882136 | 3.77 |
ENST00000311966.4
|
GLS2
|
glutaminase 2 (liver, mitochondrial) |
| chr6_+_96463840 | 3.76 |
ENST00000302103.5
|
FUT9
|
fucosyltransferase 9 (alpha (1,3) fucosyltransferase) |
| chr3_+_159943362 | 3.76 |
ENST00000326474.3
|
C3orf80
|
chromosome 3 open reading frame 80 |
| chr6_-_110500905 | 3.76 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
| chr4_-_155533787 | 3.75 |
ENST00000407946.1
ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG
|
fibrinogen gamma chain |
| chr8_+_54793454 | 3.74 |
ENST00000276500.4
|
RGS20
|
regulator of G-protein signaling 20 |
| chr7_-_108097144 | 3.74 |
ENST00000418239.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr6_-_166721871 | 3.72 |
ENST00000322583.3
|
PRR18
|
proline rich 18 |
| chrX_+_46937745 | 3.71 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
| chr3_-_42306248 | 3.70 |
ENST00000334681.5
|
CCK
|
cholecystokinin |
| chr19_+_35773242 | 3.70 |
ENST00000222304.3
|
HAMP
|
hepcidin antimicrobial peptide |
| chr18_-_24443151 | 3.68 |
ENST00000440832.3
|
AQP4
|
aquaporin 4 |
| chr2_+_242498135 | 3.68 |
ENST00000318407.3
|
BOK
|
BCL2-related ovarian killer |
| chr22_+_30792846 | 3.67 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr3_+_105086056 | 3.67 |
ENST00000472644.2
|
ALCAM
|
activated leukocyte cell adhesion molecule |
| chr17_+_79761997 | 3.66 |
ENST00000400723.3
ENST00000570996.1 |
GCGR
|
glucagon receptor |
| chr3_-_9595480 | 3.65 |
ENST00000287585.6
|
LHFPL4
|
lipoma HMGIC fusion partner-like 4 |
| chr9_+_6645887 | 3.65 |
ENST00000413145.1
|
RP11-390F4.6
|
RP11-390F4.6 |
| chr21_-_42879909 | 3.64 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
| chr2_+_17721920 | 3.64 |
ENST00000295156.4
|
VSNL1
|
visinin-like 1 |
| chr11_+_61522844 | 3.63 |
ENST00000265460.5
|
MYRF
|
myelin regulatory factor |
| chr16_-_21289627 | 3.62 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
| chr1_+_18434240 | 3.61 |
ENST00000251296.1
|
IGSF21
|
immunoglobin superfamily, member 21 |
| chr4_+_1795012 | 3.61 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
| chr9_-_97401782 | 3.60 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr19_-_16045220 | 3.59 |
ENST00000326742.8
|
CYP4F11
|
cytochrome P450, family 4, subfamily F, polypeptide 11 |
| chr11_-_134281812 | 3.59 |
ENST00000392580.1
ENST00000312527.4 |
B3GAT1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
| chr2_-_241759622 | 3.59 |
ENST00000320389.7
ENST00000498729.2 |
KIF1A
|
kinesin family member 1A |
| chr11_-_49229924 | 3.57 |
ENST00000533034.1
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1 |
| chr17_+_4802713 | 3.57 |
ENST00000521575.1
ENST00000381365.3 |
C17orf107
|
chromosome 17 open reading frame 107 |
| chr16_+_23847339 | 3.57 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr10_-_123357910 | 3.56 |
ENST00000336553.6
ENST00000457416.2 ENST00000360144.3 ENST00000369059.1 ENST00000356226.4 ENST00000351936.6 |
FGFR2
|
fibroblast growth factor receptor 2 |
| chrX_+_70435044 | 3.55 |
ENST00000374029.1
ENST00000374022.3 ENST00000447581.1 |
GJB1
|
gap junction protein, beta 1, 32kDa |
| chr4_-_819901 | 3.55 |
ENST00000304062.6
|
CPLX1
|
complexin 1 |
| chr11_-_624926 | 3.54 |
ENST00000526077.1
ENST00000534311.1 ENST00000531088.1 ENST00000397542.2 |
CDHR5
|
cadherin-related family member 5 |
| chr1_+_240255166 | 3.54 |
ENST00000319653.9
|
FMN2
|
formin 2 |
| chr2_+_115919684 | 3.54 |
ENST00000310323.8
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional) |
| chr16_+_29823427 | 3.54 |
ENST00000358758.7
ENST00000567659.1 ENST00000572820.1 |
PRRT2
|
proline-rich transmembrane protein 2 |
| chr19_-_51487071 | 3.53 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr19_-_50836762 | 3.52 |
ENST00000474951.1
ENST00000391818.2 |
KCNC3
|
potassium voltage-gated channel, Shaw-related subfamily, member 3 |
| chr2_-_208634287 | 3.52 |
ENST00000295417.3
|
FZD5
|
frizzled family receptor 5 |
| chr1_+_201979743 | 3.52 |
ENST00000446188.1
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr7_+_65670186 | 3.51 |
ENST00000304842.5
ENST00000442120.1 |
TPST1
|
tyrosylprotein sulfotransferase 1 |
| chr3_-_183979251 | 3.50 |
ENST00000296238.3
|
CAMK2N2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
| chr10_+_102729249 | 3.50 |
ENST00000519649.1
ENST00000518124.1 |
SEMA4G
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
| chr15_+_31508174 | 3.50 |
ENST00000559292.2
ENST00000557928.1 |
RP11-16E12.1
|
RP11-16E12.1 |
| chr2_+_219187871 | 3.50 |
ENST00000258362.3
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia |
| chrX_-_49056635 | 3.49 |
ENST00000472598.1
ENST00000538567.1 ENST00000479808.1 ENST00000263233.4 |
SYP
|
synaptophysin |
| chr21_-_42880075 | 3.49 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
| chr2_-_230579185 | 3.48 |
ENST00000341772.4
|
DNER
|
delta/notch-like EGF repeat containing |
| chr1_-_19615744 | 3.48 |
ENST00000361640.4
|
AKR7A3
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
| chr2_-_170219079 | 3.48 |
ENST00000263816.3
|
LRP2
|
low density lipoprotein receptor-related protein 2 |
| chr9_-_116861337 | 3.46 |
ENST00000374118.3
|
KIF12
|
kinesin family member 12 |
| chr11_-_119293872 | 3.46 |
ENST00000524970.1
|
THY1
|
Thy-1 cell surface antigen |
| chrX_-_13956497 | 3.46 |
ENST00000398361.3
|
GPM6B
|
glycoprotein M6B |
| chr21_-_44495964 | 3.45 |
ENST00000398168.1
ENST00000398165.3 |
CBS
|
cystathionine-beta-synthase |
| chr3_+_63263788 | 3.45 |
ENST00000478300.1
|
SYNPR
|
synaptoporin |
| chr5_-_176057365 | 3.45 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
| chr2_+_231902193 | 3.43 |
ENST00000373640.4
|
C2orf72
|
chromosome 2 open reading frame 72 |
| chr17_+_29718642 | 3.43 |
ENST00000325874.8
|
RAB11FIP4
|
RAB11 family interacting protein 4 (class II) |
| chrX_-_13956737 | 3.42 |
ENST00000454189.2
|
GPM6B
|
glycoprotein M6B |
| chr1_+_40420802 | 3.42 |
ENST00000372811.5
ENST00000420632.2 ENST00000434861.1 ENST00000372809.5 |
MFSD2A
|
major facilitator superfamily domain containing 2A |
| chr16_+_25703274 | 3.41 |
ENST00000331351.5
|
HS3ST4
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
| chr16_+_89894875 | 3.41 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
| chr14_+_95078714 | 3.41 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
| chr8_-_11324273 | 3.41 |
ENST00000284486.4
|
FAM167A
|
family with sequence similarity 167, member A |
| chr22_+_30792980 | 3.40 |
ENST00000403484.1
ENST00000405717.3 ENST00000402592.3 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr16_+_2198604 | 3.40 |
ENST00000210187.6
|
RAB26
|
RAB26, member RAS oncogene family |
| chr11_-_49230184 | 3.40 |
ENST00000340334.7
ENST00000256999.2 |
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1 |
| chr1_-_40782938 | 3.39 |
ENST00000372736.3
ENST00000372748.3 |
COL9A2
|
collagen, type IX, alpha 2 |
| chr10_+_134973905 | 3.38 |
ENST00000304613.3
ENST00000368572.2 |
KNDC1
|
kinase non-catalytic C-lobe domain (KIND) containing 1 |
| chr7_+_121513374 | 3.38 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
| chr19_-_16045665 | 3.38 |
ENST00000248041.8
|
CYP4F11
|
cytochrome P450, family 4, subfamily F, polypeptide 11 |
| chr19_+_2977444 | 3.38 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
| chr1_+_161228517 | 3.37 |
ENST00000504449.1
|
PCP4L1
|
Purkinje cell protein 4 like 1 |
| chr16_+_68771128 | 3.37 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
| chr14_-_65438865 | 3.36 |
ENST00000267512.5
|
RAB15
|
RAB15, member RAS oncogene family |
| chr1_+_70876891 | 3.36 |
ENST00000411986.2
|
CTH
|
cystathionase (cystathionine gamma-lyase) |
| chr11_+_20691195 | 3.36 |
ENST00000532434.1
|
NELL1
|
NEL-like 1 (chicken) |
| chr14_-_94856951 | 3.36 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr19_+_4279282 | 3.35 |
ENST00000599689.1
|
SHD
|
Src homology 2 domain containing transforming protein D |
| chr12_-_56881874 | 3.35 |
ENST00000539272.1
|
GLS2
|
glutaminase 2 (liver, mitochondrial) |
| chr19_+_15752088 | 3.34 |
ENST00000585846.1
|
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of RCOR1_MTA3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.5 | 16.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 4.1 | 16.5 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 4.1 | 12.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 3.8 | 11.3 | GO:0048627 | myoblast development(GO:0048627) |
| 3.7 | 3.7 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 3.4 | 10.1 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 3.3 | 13.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 3.1 | 6.3 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
| 3.0 | 9.0 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 3.0 | 8.9 | GO:0060621 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 2.9 | 11.8 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.7 | 2.7 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 2.6 | 7.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 2.5 | 15.2 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 2.5 | 7.6 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 2.5 | 12.6 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 2.5 | 9.9 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 2.5 | 17.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 2.4 | 12.2 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 2.4 | 2.4 | GO:0043318 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 2.4 | 4.9 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 2.4 | 7.3 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 2.4 | 4.8 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 2.3 | 9.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 2.3 | 9.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.3 | 9.0 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 2.2 | 8.7 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 2.2 | 8.6 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 2.1 | 4.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 2.1 | 6.3 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 2.1 | 16.7 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 2.0 | 12.2 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 2.0 | 6.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 2.0 | 21.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.9 | 7.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 1.9 | 5.8 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 1.9 | 11.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.9 | 7.6 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 1.9 | 15.2 | GO:0006562 | proline catabolic process(GO:0006562) |
| 1.9 | 5.6 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 1.9 | 5.6 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 1.8 | 5.5 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 1.8 | 9.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.8 | 5.3 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 1.7 | 12.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.7 | 6.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 1.7 | 6.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 1.7 | 3.4 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 1.7 | 5.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 1.7 | 8.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.7 | 10.1 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 1.7 | 5.1 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.7 | 8.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 1.7 | 11.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 1.7 | 5.0 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 1.7 | 8.3 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 1.7 | 5.0 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.6 | 3.3 | GO:0070166 | enamel mineralization(GO:0070166) |
| 1.6 | 1.6 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 1.6 | 4.9 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 1.6 | 4.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 1.6 | 20.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 1.6 | 3.1 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.5 | 4.6 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 1.5 | 27.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 1.5 | 12.3 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 1.5 | 6.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 1.5 | 1.5 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 1.5 | 4.5 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 1.5 | 3.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 1.5 | 4.5 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 1.5 | 10.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 1.5 | 4.4 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 1.5 | 7.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.5 | 7.3 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 1.5 | 4.4 | GO:0007497 | posterior midgut development(GO:0007497) |
| 1.4 | 2.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 1.4 | 5.8 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 1.4 | 1.4 | GO:0044088 | regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
| 1.4 | 8.5 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 1.4 | 4.3 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.4 | 4.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.4 | 1.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 1.4 | 12.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.4 | 15.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 1.4 | 6.9 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 1.4 | 5.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 1.4 | 5.5 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 1.4 | 4.1 | GO:0071559 | response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 1.4 | 17.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 1.3 | 5.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 1.3 | 4.0 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.3 | 4.0 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.3 | 46.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 1.3 | 6.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 1.3 | 19.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.3 | 6.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 1.3 | 6.6 | GO:0043335 | protein unfolding(GO:0043335) |
| 1.3 | 5.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 1.3 | 5.2 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 1.3 | 17.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.3 | 1.3 | GO:0050807 | regulation of synapse organization(GO:0050807) |
| 1.3 | 5.1 | GO:0090260 | negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 1.3 | 26.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.3 | 5.1 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 1.3 | 8.9 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 1.3 | 8.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.3 | 11.4 | GO:0046618 | drug export(GO:0046618) |
| 1.3 | 6.3 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.3 | 3.8 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
| 1.2 | 1.2 | GO:0001656 | metanephros development(GO:0001656) |
| 1.2 | 6.2 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 1.2 | 3.7 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 1.2 | 1.2 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 1.2 | 2.4 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 1.2 | 4.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 1.2 | 4.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 1.2 | 6.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 1.2 | 8.4 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 1.2 | 8.4 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 1.2 | 7.2 | GO:0042335 | cuticle development(GO:0042335) |
| 1.2 | 6.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 1.2 | 14.3 | GO:0015942 | formate metabolic process(GO:0015942) |
| 1.2 | 4.8 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 1.2 | 11.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.2 | 7.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 1.2 | 5.9 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
| 1.2 | 3.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 1.2 | 5.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 1.2 | 4.7 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.2 | 3.5 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 1.2 | 3.5 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 1.2 | 3.5 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 1.2 | 6.9 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 1.2 | 4.6 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 1.1 | 4.6 | GO:0014011 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 1.1 | 8.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 1.1 | 3.4 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 1.1 | 1.1 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 1.1 | 6.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 1.1 | 15.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 1.1 | 3.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 1.1 | 4.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.1 | 2.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 1.1 | 5.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 1.1 | 3.3 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.1 | 5.5 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 1.1 | 3.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 1.1 | 3.3 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 1.1 | 3.3 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
| 1.1 | 3.3 | GO:0050894 | determination of affect(GO:0050894) |
| 1.1 | 2.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 1.1 | 3.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.1 | 5.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.1 | 5.4 | GO:0019695 | choline metabolic process(GO:0019695) |
| 1.1 | 8.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.1 | 3.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.1 | 4.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 1.1 | 8.5 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 1.1 | 6.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.1 | 11.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 1.1 | 13.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 1.1 | 2.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 1.0 | 3.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.0 | 3.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.0 | 20.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.0 | 6.2 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 1.0 | 10.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 1.0 | 18.5 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 1.0 | 3.1 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 1.0 | 5.1 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 1.0 | 6.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 1.0 | 2.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 1.0 | 6.1 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 1.0 | 1.0 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
| 1.0 | 3.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 1.0 | 5.1 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 1.0 | 1.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.0 | 10.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.0 | 4.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 1.0 | 4.0 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 1.0 | 3.0 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 1.0 | 9.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 1.0 | 1.0 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 1.0 | 11.8 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.0 | 1.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
| 1.0 | 4.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 1.0 | 1.0 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 1.0 | 6.8 | GO:0008218 | bioluminescence(GO:0008218) |
| 1.0 | 4.8 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.0 | 3.9 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 1.0 | 6.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.0 | 6.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 1.0 | 3.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.0 | 9.6 | GO:0009414 | response to water deprivation(GO:0009414) |
| 1.0 | 2.9 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.0 | 2.9 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.9 | 11.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.9 | 3.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.9 | 2.8 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.9 | 1.9 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.9 | 2.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.9 | 3.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.9 | 4.6 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.9 | 1.9 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.9 | 9.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.9 | 2.8 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.9 | 5.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.9 | 1.8 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.9 | 47.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.9 | 3.7 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.9 | 4.6 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.9 | 2.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.9 | 3.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.9 | 33.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.9 | 0.9 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.9 | 4.5 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.9 | 3.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.9 | 5.4 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.9 | 5.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.9 | 2.7 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.9 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
| 0.9 | 0.9 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 0.9 | 2.7 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.9 | 7.1 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.9 | 1.8 | GO:0031214 | biomineral tissue development(GO:0031214) |
| 0.9 | 5.3 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.9 | 7.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.9 | 2.7 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.9 | 2.6 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.9 | 0.9 | GO:0048066 | developmental pigmentation(GO:0048066) |
| 0.9 | 16.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.9 | 3.5 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.9 | 4.4 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.9 | 1.7 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.9 | 8.7 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.9 | 3.5 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.9 | 0.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.9 | 1.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.9 | 0.9 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.9 | 1.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.9 | 4.3 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.9 | 1.7 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.9 | 3.4 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
| 0.9 | 2.6 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.9 | 5.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.8 | 5.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.8 | 0.8 | GO:0061055 | myotome development(GO:0061055) |
| 0.8 | 9.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.8 | 4.2 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.8 | 5.0 | GO:0030421 | defecation(GO:0030421) |
| 0.8 | 1.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.8 | 0.8 | GO:0060458 | right lung development(GO:0060458) |
| 0.8 | 1.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.8 | 5.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.8 | 18.1 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.8 | 2.5 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.8 | 4.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.8 | 2.5 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.8 | 2.5 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.8 | 2.4 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.8 | 4.0 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.8 | 8.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
| 0.8 | 0.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.8 | 16.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.8 | 0.8 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.8 | 1.6 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.8 | 0.8 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
| 0.8 | 2.4 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.8 | 6.4 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.8 | 2.4 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.8 | 4.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.8 | 5.5 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.8 | 5.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.8 | 11.0 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.8 | 12.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 0.8 | 2.4 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.8 | 10.2 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.8 | 3.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.8 | 3.9 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.8 | 3.1 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.8 | 3.9 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.8 | 1.6 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
| 0.8 | 2.3 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
| 0.8 | 2.3 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.8 | 0.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.8 | 2.3 | GO:0043473 | pigmentation(GO:0043473) |
| 0.8 | 0.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.8 | 7.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.8 | 1.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.8 | 0.8 | GO:0043901 | negative regulation of multi-organism process(GO:0043901) |
| 0.8 | 12.9 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.8 | 14.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.7 | 0.7 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.7 | 1.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.7 | 0.7 | GO:0036314 | response to sterol(GO:0036314) |
| 0.7 | 2.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.7 | 10.4 | GO:0003096 | renal sodium ion transport(GO:0003096) |
| 0.7 | 21.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.7 | 3.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.7 | 3.0 | GO:0097503 | sialylation(GO:0097503) |
| 0.7 | 10.4 | GO:0009415 | response to water(GO:0009415) |
| 0.7 | 2.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.7 | 3.0 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.7 | 2.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.7 | 1.5 | GO:0043132 | NAD transport(GO:0043132) |
| 0.7 | 0.7 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
| 0.7 | 0.7 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 0.7 | 1.5 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 | 0.7 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.7 | 29.3 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.7 | 0.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.7 | 1.5 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.7 | 2.9 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.7 | 2.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.7 | 9.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.7 | 5.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.7 | 30.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.7 | 10.1 | GO:0015816 | glycine transport(GO:0015816) |
| 0.7 | 1.4 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.7 | 2.9 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.7 | 8.6 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.7 | 2.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.7 | 8.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.7 | 10.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.7 | 1.4 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.7 | 2.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.7 | 3.6 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.7 | 2.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.7 | 5.7 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.7 | 19.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.7 | 2.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.7 | 2.1 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.7 | 1.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.7 | 11.2 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.7 | 2.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.7 | 2.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.7 | 6.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.7 | 2.0 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.7 | 0.7 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.7 | 5.5 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.7 | 2.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.7 | 2.0 | GO:0048925 | lateral line system development(GO:0048925) |
| 0.7 | 1.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.7 | 10.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.7 | 0.7 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.7 | 8.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.7 | 0.7 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.7 | 2.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.7 | 3.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 0.7 | 4.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.7 | 0.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.7 | 4.0 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.7 | 18.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.7 | 2.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.7 | 1.3 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.7 | 2.7 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.7 | 2.0 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.7 | 4.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.7 | 0.7 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.7 | 0.7 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
| 0.7 | 7.2 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.7 | 9.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.7 | 2.6 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.7 | 5.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.7 | 1.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.7 | 7.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.7 | 2.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.6 | 0.6 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
| 0.6 | 2.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.6 | 1.9 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.6 | 6.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.6 | 4.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.6 | 5.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.6 | 11.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.6 | 5.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.6 | 0.6 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.6 | 37.6 | GO:0090382 | phagosome maturation(GO:0090382) |
| 0.6 | 1.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.6 | 2.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.6 | 1.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.6 | 1.9 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.6 | 3.8 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.6 | 13.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.6 | 9.4 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.6 | 0.6 | GO:0060021 | palate development(GO:0060021) |
| 0.6 | 2.5 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.6 | 1.2 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
| 0.6 | 0.6 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.6 | 0.6 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.6 | 1.9 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.6 | 3.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.6 | 9.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.6 | 1.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.6 | 0.6 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.6 | 3.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.6 | 1.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.6 | 3.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.6 | 1.8 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.6 | 1.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.6 | 2.5 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.6 | 1.8 | GO:0050893 | sensory processing(GO:0050893) |
| 0.6 | 6.1 | GO:0015677 | copper ion import(GO:0015677) |
| 0.6 | 2.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.6 | 1.2 | GO:0097695 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.6 | 6.1 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.6 | 1.8 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.6 | 5.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.6 | 1.8 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.6 | 1.8 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.6 | 1.8 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.6 | 1.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.6 | 2.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.6 | 5.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.6 | 1.8 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.6 | 1.8 | GO:0021764 | amygdala development(GO:0021764) |
| 0.6 | 9.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.6 | 3.0 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.6 | 2.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.6 | 1.8 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.6 | 2.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.6 | 9.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.6 | 8.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.6 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.6 | 2.4 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.6 | 3.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.6 | 6.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.6 | 3.6 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.6 | 3.6 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.6 | 2.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.6 | 3.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.6 | 4.7 | GO:0032439 | endosome localization(GO:0032439) |
| 0.6 | 1.2 | GO:0007422 | peripheral nervous system development(GO:0007422) |
| 0.6 | 0.6 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.6 | 7.6 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.6 | 2.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.6 | 4.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.6 | 1.8 | GO:1905204 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.6 | 1.8 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
| 0.6 | 2.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.6 | 3.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.6 | 1.7 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.6 | 1.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.6 | 9.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.6 | 8.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.6 | 2.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.6 | 4.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.6 | 4.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.6 | 4.0 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.6 | 0.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.6 | 5.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.6 | 2.9 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.6 | 1.7 | GO:0030070 | insulin processing(GO:0030070) |
| 0.6 | 16.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.6 | 1.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.6 | 0.6 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.6 | 8.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.6 | 14.2 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.6 | 0.6 | GO:0032328 | alanine transport(GO:0032328) |
| 0.6 | 3.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.6 | 6.2 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.6 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.6 | 1.7 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.6 | 7.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.6 | 1.7 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.6 | 7.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.6 | 5.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.6 | 4.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.6 | 1.1 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.6 | 2.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.6 | 1.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.6 | 1.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.6 | 2.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.6 | 3.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.6 | 1.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.6 | 10.5 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 0.6 | 2.2 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.5 | 1.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.5 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
| 0.5 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.5 | 1.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.5 | 6.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.5 | 4.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.5 | 2.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.5 | 8.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.5 | 7.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.5 | 12.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.5 | 2.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.5 | 4.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.5 | 0.5 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.5 | 11.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.5 | 3.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.5 | 3.8 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 0.5 | 4.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.5 | 32.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.5 | 1.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.5 | 1.6 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 | 0.5 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.5 | 2.1 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.5 | 1.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.5 | 0.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.5 | 1.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.5 | 2.6 | GO:0014028 | notochord formation(GO:0014028) |
| 0.5 | 4.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.5 | 0.5 | GO:0060359 | response to ammonium ion(GO:0060359) |
| 0.5 | 8.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.5 | 4.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.5 | 0.5 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.5 | 2.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.5 | 8.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.5 | 1.6 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.5 | 6.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.5 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.5 | 5.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.5 | 0.5 | GO:0060435 | bronchiole development(GO:0060435) |
| 0.5 | 2.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 | 2.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.5 | 6.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.5 | 1.5 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.5 | 0.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.5 | 0.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.5 | 8.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.5 | 0.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.5 | 4.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.5 | 0.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
| 0.5 | 2.0 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.5 | 11.2 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.5 | 2.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.5 | 2.0 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.5 | 2.0 | GO:0031344 | regulation of cell projection organization(GO:0031344) |
| 0.5 | 0.5 | GO:0051029 | rRNA transport(GO:0051029) |
| 0.5 | 3.6 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.5 | 1.5 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.5 | 0.5 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.5 | 2.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 | 2.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.5 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.5 | 3.5 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.5 | 1.5 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.5 | 2.0 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.5 | 3.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.5 | 4.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.5 | 3.5 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.5 | 7.5 | GO:0015705 | iodide transport(GO:0015705) |
| 0.5 | 2.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.5 | 2.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.5 | 1.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.5 | 4.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.5 | 4.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.5 | 3.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.5 | 3.5 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.5 | 1.0 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.5 | 0.5 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
| 0.5 | 2.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.5 | 4.9 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.5 | 1.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.5 | 1.0 | GO:0072657 | protein localization to membrane(GO:0072657) |
| 0.5 | 1.0 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.5 | 1.9 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.5 | 7.7 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.5 | 1.0 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.5 | 1.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.5 | 1.0 | GO:0048793 | pronephros development(GO:0048793) |
| 0.5 | 2.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.5 | 2.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.5 | 1.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.5 | 1.9 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.5 | 1.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.5 | 0.5 | GO:0070838 | divalent metal ion transport(GO:0070838) |
| 0.5 | 2.4 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.5 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.5 | 1.0 | GO:1905154 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) negative regulation of membrane invagination(GO:1905154) |
| 0.5 | 2.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.5 | 7.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.5 | 1.0 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.5 | 0.5 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
| 0.5 | 1.4 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.5 | 3.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.5 | 1.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.5 | 19.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.5 | 0.9 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.5 | 8.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.5 | 1.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.5 | 10.8 | GO:0051923 | sulfation(GO:0051923) |
| 0.5 | 0.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.5 | 1.4 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.5 | 1.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.5 | 1.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.5 | 1.4 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.5 | 7.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.5 | 4.6 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.5 | 3.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.5 | 3.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.5 | 3.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.5 | 1.4 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.5 | 2.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.5 | 0.5 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.5 | 1.8 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.5 | 0.9 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.5 | 5.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.5 | 3.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.5 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.5 | 3.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.5 | 1.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.5 | 4.1 | GO:0043545 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.5 | 10.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.5 | 5.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.4 | 4.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.4 | 4.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.4 | 4.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.4 | 0.9 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.4 | 6.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.4 | 1.8 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.4 | 3.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.4 | 1.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.4 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.4 | 1.8 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.4 | 0.4 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
| 0.4 | 4.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.4 | 3.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.4 | 1.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.4 | 0.9 | GO:0034754 | cellular hormone metabolic process(GO:0034754) |
| 0.4 | 1.3 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.4 | 2.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.4 | 1.3 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
| 0.4 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.4 | 2.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.4 | 5.7 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.4 | 1.3 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.4 | 4.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 | 1.8 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.4 | 1.3 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.4 | 0.9 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.4 | 3.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.4 | 2.2 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
| 0.4 | 6.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.4 | 1.8 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.4 | 2.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.4 | 1.3 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.4 | 0.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.4 | 11.3 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.4 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.4 | 0.4 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.4 | 5.7 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.4 | 3.5 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.4 | 1.3 | GO:0050955 | thermoception(GO:0050955) |
| 0.4 | 2.6 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.4 | 4.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 0.9 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
| 0.4 | 2.6 | GO:1901374 | acetate ester transport(GO:1901374) |
| 0.4 | 1.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.4 | 0.4 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.4 | 3.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.4 | 4.3 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.4 | 3.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.4 | 1.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 1.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.4 | 0.9 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.4 | 4.7 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
| 0.4 | 0.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.4 | 2.5 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.4 | 2.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.4 | 2.5 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.4 | 1.3 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.4 | 4.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.4 | 3.8 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.4 | 3.8 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.4 | 6.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.4 | 2.5 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.4 | 1.7 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.4 | 2.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.4 | 2.5 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.4 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.4 | 12.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.4 | 3.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.4 | 3.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.4 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.4 | 4.9 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.4 | 0.8 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.4 | 2.9 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
| 0.4 | 2.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 | 53.4 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
| 0.4 | 1.2 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.4 | 2.0 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.4 | 0.8 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.4 | 3.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.4 | 2.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 | 2.0 | GO:0098754 | detoxification(GO:0098754) |
| 0.4 | 10.9 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.4 | 5.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.4 | 0.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.4 | 7.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.4 | 6.8 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.4 | 4.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.4 | 2.0 | GO:0097286 | iron ion import(GO:0097286) |
| 0.4 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.4 | 0.4 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.4 | 1.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 | 8.7 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.4 | 2.8 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.4 | 1.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.4 | 4.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.4 | 0.8 | GO:0050904 | diapedesis(GO:0050904) |
| 0.4 | 3.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.4 | 5.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 | 0.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.4 | 0.8 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 0.4 | 0.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.4 | 9.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.4 | 1.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.4 | 1.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.4 | 0.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.4 | 2.7 | GO:0015824 | proline transport(GO:0015824) |
| 0.4 | 4.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.4 | 1.9 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.4 | 0.8 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.4 | 4.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.4 | 2.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.4 | 1.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.4 | 0.4 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.4 | 1.5 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.4 | 1.9 | GO:0048749 | compound eye development(GO:0048749) |
| 0.4 | 1.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.4 | 2.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.4 | 1.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.4 | 0.8 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.4 | 3.8 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.4 | 2.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.4 | 3.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.4 | 6.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.4 | 4.1 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.4 | 0.8 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
| 0.4 | 3.8 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
| 0.4 | 7.1 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
| 0.4 | 1.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.4 | 0.7 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.4 | 0.4 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 0.4 | 8.9 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.4 | 23.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.4 | 2.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 1.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.4 | 1.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.4 | 0.4 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.4 | 3.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.4 | 1.5 | GO:1901159 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.4 | 3.0 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
| 0.4 | 1.8 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.4 | 1.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
| 0.4 | 1.8 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.4 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
| 0.4 | 4.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.4 | 8.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.4 | 1.1 | GO:0006598 | polyamine catabolic process(GO:0006598) spermidine catabolic process(GO:0046203) |
| 0.4 | 1.1 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.4 | 1.8 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.4 | 4.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.4 | 3.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 | 0.4 | GO:0006790 | sulfur compound metabolic process(GO:0006790) |
| 0.4 | 1.1 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.4 | 1.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.4 | 2.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.4 | 3.6 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.4 | 0.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.4 | 1.4 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.4 | 1.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.4 | 6.1 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.4 | 2.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.4 | 1.1 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.4 | 2.9 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.4 | 0.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.4 | 7.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.4 | 7.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.4 | 3.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.4 | 2.8 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.4 | 2.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.4 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.4 | 5.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.3 | 0.7 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.3 | 15.4 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.3 | 12.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.3 | 2.8 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.3 | 0.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 | 0.7 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.3 | 0.7 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.3 | 4.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.3 | 1.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.3 | 5.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.3 | 4.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.3 | 1.0 | GO:0010044 | response to aluminum ion(GO:0010044) oxidation-dependent protein catabolic process(GO:0070407) |
| 0.3 | 16.2 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.3 | 5.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.3 | 8.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.3 | 0.7 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.3 | 2.7 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.3 | 1.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 | 1.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.3 | 1.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.3 | 1.4 | GO:0033080 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) |
| 0.3 | 1.0 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.3 | 0.7 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
| 0.3 | 6.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 | 3.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 | 5.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 | 0.3 | GO:2000981 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.3 | 1.7 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.3 | 2.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.3 | 0.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.3 | 1.0 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.3 | 1.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 | 0.3 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.3 | 1.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 3.0 | GO:0070977 | bone maturation(GO:0070977) |
| 0.3 | 0.3 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
| 0.3 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 | 0.7 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.3 | 10.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.3 | 1.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.3 | 0.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.3 | 2.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.3 | 1.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.3 | 2.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.3 | 1.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.3 | 1.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.3 | 3.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.3 | 1.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.3 | 1.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.3 | 5.2 | GO:0015893 | drug transport(GO:0015893) |
| 0.3 | 0.6 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.3 | 3.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.3 | 23.3 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.3 | 1.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.3 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.3 | 1.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.3 | 0.3 | GO:0060371 | response to pyrethroid(GO:0046684) regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.3 | 4.2 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
| 0.3 | 0.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.3 | 0.6 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.3 | 9.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 3.8 | GO:0001964 | startle response(GO:0001964) |
| 0.3 | 5.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.3 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.3 | 0.3 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.3 | 3.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.3 | 0.6 | GO:0070091 | glucagon secretion(GO:0070091) |
| 0.3 | 1.6 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 0.3 | 1.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.3 | 1.0 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.3 | 16.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.3 | 0.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.3 | 1.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.3 | 1.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.3 | 0.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.3 | 0.3 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
| 0.3 | 11.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.3 | 0.6 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.3 | 1.3 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.3 | 2.5 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
| 0.3 | 1.6 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.3 | 0.9 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.3 | 0.3 | GO:0007623 | circadian rhythm(GO:0007623) |
| 0.3 | 0.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.3 | 0.3 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.3 | 2.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.3 | 1.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.3 | 2.2 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.3 | 1.6 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.3 | 1.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.3 | 0.9 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.3 | 1.9 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.3 | 10.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.3 | 0.6 | GO:0033500 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
| 0.3 | 1.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.3 | 4.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.3 | 13.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.3 | 5.8 | GO:0046037 | GMP metabolic process(GO:0046037) |
| 0.3 | 0.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.3 | 1.8 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 | 0.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.3 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
| 0.3 | 3.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.3 | 1.5 | GO:0035864 | response to potassium ion(GO:0035864) |
| 0.3 | 10.3 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.3 | 3.9 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.3 | 6.0 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.3 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.3 | 0.9 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.3 | 2.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.3 | 0.9 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.3 | 2.1 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.3 | 0.6 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.3 | 2.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.3 | 4.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 1.5 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.3 | 0.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.3 | 1.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.3 | 9.2 | GO:0042026 | protein refolding(GO:0042026) |
| 0.3 | 3.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.3 | 0.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 0.3 | 1.2 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.3 | 1.5 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 | 1.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.3 | 1.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.3 | 4.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.3 | 4.1 | GO:0051597 | response to methylmercury(GO:0051597) |
| 0.3 | 0.9 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.3 | 1.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 | 6.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.3 | 0.3 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.3 | 0.3 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.3 | 14.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.3 | 0.3 | GO:0046782 | regulation of viral transcription(GO:0046782) |
| 0.3 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.3 | 1.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.3 | 8.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.3 | 0.6 | GO:0015865 | purine nucleotide transport(GO:0015865) |
| 0.3 | 8.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.3 | 2.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.3 | 1.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.3 | 1.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.3 | 2.3 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.3 | 1.1 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 0.3 | 1.1 | GO:0042000 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.3 | 2.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.3 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.3 | 7.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.3 | 0.8 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.3 | 0.8 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.3 | 2.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.3 | 3.9 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.3 | 4.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.3 | 2.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.3 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.3 | 4.7 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.3 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.3 | 10.7 | GO:0008542 | visual learning(GO:0008542) |
| 0.3 | 2.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
| 0.3 | 1.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 | 2.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.3 | 1.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 | 5.2 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.3 | 0.5 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.3 | 0.8 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.3 | 0.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
| 0.3 | 5.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.3 | 2.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.3 | 0.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.3 | 1.1 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.3 | 0.3 | GO:0018209 | peptidyl-serine modification(GO:0018209) |
| 0.3 | 16.8 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.3 | 0.3 | GO:0048878 | chemical homeostasis(GO:0048878) |
| 0.3 | 0.3 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
| 0.3 | 0.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 | 0.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 0.8 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
| 0.3 | 1.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 | 0.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.3 | 0.3 | GO:0060326 | cell chemotaxis(GO:0060326) |
| 0.3 | 1.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.3 | 1.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.3 | 1.0 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.3 | 2.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 | 1.8 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.3 | 9.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.3 | 0.5 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.3 | 10.1 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.3 | 1.3 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) peptidyl-glutamine modification(GO:0018199) isopeptide cross-linking(GO:0018262) |
| 0.3 | 5.9 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.3 | 1.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 1.0 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.3 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.3 | 0.8 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.3 | 2.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 | 3.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 0.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 | 2.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.3 | 2.0 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.3 | 1.5 | GO:0032264 | IMP salvage(GO:0032264) nucleotide salvage(GO:0043173) |
| 0.3 | 0.8 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 | 0.8 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.3 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.3 | 0.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 | 4.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 | 1.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.3 | 1.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 4.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.2 | 0.2 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
| 0.2 | 0.2 | GO:0042440 | pigment metabolic process(GO:0042440) |
| 0.2 | 5.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 | 0.7 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.2 | 0.7 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 | 8.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.2 | 0.2 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.2 | 1.0 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.2 | 13.8 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.2 | 0.5 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.2 | 1.2 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.2 | 0.5 | GO:0006067 | ethanol metabolic process(GO:0006067) |
| 0.2 | 0.5 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.2 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.2 | 0.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.2 | 0.7 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 0.2 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.2 | 4.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.2 | 0.7 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) positive regulation of antigen processing and presentation(GO:0002579) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.2 | 0.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
| 0.2 | 0.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.2 | 0.5 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
| 0.2 | 2.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 | 1.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 6.0 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.2 | 1.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 | 0.5 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
| 0.2 | 16.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 1.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 | 1.2 | GO:0099637 | neurotransmitter receptor transport(GO:0099637) |
| 0.2 | 1.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.2 | 1.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 3.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
| 0.2 | 0.5 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.2 | 0.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 | 2.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.2 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 2.1 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 1.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.2 | 1.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.2 | 0.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.2 | 0.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.2 | 1.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.2 | 1.2 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.2 | 4.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 | 4.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 | 0.5 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
| 0.2 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 | 1.2 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.2 | 1.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.2 | 2.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 | 1.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.2 | 0.9 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.2 | 1.1 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.2 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 0.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 | 1.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.2 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 | 2.0 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.2 | 0.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.2 | 2.0 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 | 2.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.2 | 0.9 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.2 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 | 0.2 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 | 1.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 | 1.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 1.1 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.2 | 0.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.2 | 4.0 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 0.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 | 0.7 | GO:0055088 | lipid homeostasis(GO:0055088) |
| 0.2 | 0.2 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 0.7 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.2 | 2.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.2 | 2.0 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 | 0.9 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.2 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.2 | 2.2 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.2 | 1.3 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.2 | 0.7 | GO:0015800 | acidic amino acid transport(GO:0015800) |
| 0.2 | 0.2 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
| 0.2 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 0.6 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.2 | 0.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.2 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.2 | 5.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.2 | 2.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.2 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.2 | 0.2 | GO:0010043 | response to zinc ion(GO:0010043) |
| 0.2 | 1.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 | 0.4 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.2 | 3.6 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.2 | 1.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.2 | 5.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
| 0.2 | 4.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.2 | 10.8 | GO:0007602 | phototransduction(GO:0007602) |
| 0.2 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.2 | 3.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 | 8.0 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.2 | 6.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.2 | 2.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 | 1.0 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.2 | 6.8 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
| 0.2 | 1.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 | 1.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 | 1.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.2 | 0.2 | GO:0060429 | epithelium development(GO:0060429) |
| 0.2 | 0.6 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.2 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 | 0.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.2 | 0.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.2 | 0.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.2 | 1.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 | 0.8 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 1.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.2 | 2.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 0.4 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.2 | 1.0 | GO:0043163 | positive regulation of keratinocyte proliferation(GO:0010838) cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.2 | 1.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 | 0.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 1.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.2 | 0.8 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
| 0.2 | 3.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 33.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 0.6 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 0.2 | 0.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.2 | 3.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 0.6 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.2 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 5.5 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.2 | 0.6 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.2 | 2.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 | 4.1 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.2 | 8.3 | GO:0007416 | synapse assembly(GO:0007416) |
| 0.2 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.2 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
| 0.2 | 1.0 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
| 0.2 | 0.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.2 | 0.2 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.2 | 0.4 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.2 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 1.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.2 | 0.4 | GO:0048678 | response to axon injury(GO:0048678) |
| 0.2 | 0.6 | GO:0019400 | alditol metabolic process(GO:0019400) |
| 0.2 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.2 | 0.6 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 | 0.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.2 | 0.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.2 | 0.6 | GO:0021587 | cerebellum morphogenesis(GO:0021587) |
| 0.2 | 1.9 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
| 0.2 | 0.8 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.2 | 0.4 | GO:0043217 | myelin maintenance(GO:0043217) |
| 0.2 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 | 1.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.2 | 2.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.2 | 0.7 | GO:0009310 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
| 0.2 | 0.7 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 | 1.7 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.2 | 1.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 | 11.4 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
| 0.2 | 1.5 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
| 0.2 | 1.8 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.2 | 0.6 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.2 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.2 | 0.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 8.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 | 3.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.2 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 | 0.2 | GO:0048144 | fibroblast proliferation(GO:0048144) |
| 0.2 | 0.9 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 | 0.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.2 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 1.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.2 | 2.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.2 | 1.4 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.2 | 0.7 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
| 0.2 | 0.5 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 | 2.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.2 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
| 0.2 | 0.5 | GO:1904585 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.2 | 2.0 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.2 | 2.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
| 0.2 | 2.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.2 | 0.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 0.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.2 | 0.5 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
| 0.2 | 2.1 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.2 | 1.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 0.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.2 | 0.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 1.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 | 2.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.2 | 1.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.2 | 1.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 9.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.2 | 0.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.2 | 0.5 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
| 0.2 | 4.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.2 | 0.9 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.2 | 0.2 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.2 | 3.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.2 | 0.5 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
| 0.2 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 | 0.9 | GO:0046849 | bone remodeling(GO:0046849) |
| 0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 | 4.5 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.2 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.2 | 0.7 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.2 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 | 3.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 0.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.2 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.2 | 1.4 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.2 | 0.7 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 | 0.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.2 | 3.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.2 | 1.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.2 | 2.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 3.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.2 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.2 | 0.5 | GO:0051180 | vitamin transport(GO:0051180) |
| 0.2 | 1.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.2 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 1.0 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.2 | 0.2 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.2 | 1.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.2 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.2 | 1.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 | 0.3 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
| 0.2 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.2 | 0.5 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
| 0.2 | 0.6 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.2 | 0.5 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.2 | 0.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.2 | 0.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.2 | 1.3 | GO:0043542 | endothelial cell migration(GO:0043542) |
| 0.2 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.2 | 0.9 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.2 | 0.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.2 | 0.5 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.2 | 2.6 | GO:0097502 | mannosylation(GO:0097502) |
| 0.2 | 11.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.2 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.2 | 3.9 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.2 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 0.6 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.2 | 4.0 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.2 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 | 0.8 | GO:0021781 | glial cell fate commitment(GO:0021781) |
| 0.2 | 1.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.2 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.2 | 0.3 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
| 0.2 | 0.3 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.2 | 1.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 | 0.3 | GO:0060548 | negative regulation of cell death(GO:0060548) |
| 0.2 | 0.3 | GO:0042407 | inner mitochondrial membrane organization(GO:0007007) cristae formation(GO:0042407) |
| 0.2 | 0.6 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.1 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.6 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.1 | 0.1 | GO:0007369 | gastrulation(GO:0007369) |
| 0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.1 | 0.7 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 11.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 0.4 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.1 | 2.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 3.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 2.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.1 | 0.7 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 7.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 4.8 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.1 | 0.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 2.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 1.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 | 6.5 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 | 0.7 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 | 0.9 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 | 1.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 2.3 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.1 | 0.7 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 0.3 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
| 0.1 | 0.9 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.1 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 0.7 | GO:0045007 | depurination(GO:0045007) |
| 0.1 | 3.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 13.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 0.6 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.1 | 2.0 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 3.8 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 0.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 2.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.1 | 5.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.1 | 1.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.1 | 0.4 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.1 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 0.3 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 | 1.2 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 1.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 10.3 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
| 0.1 | 0.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 0.3 | GO:1990089 | response to nerve growth factor(GO:1990089) |
| 0.1 | 1.2 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.1 | 2.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.1 | 1.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 | 0.1 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.1 | 0.8 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 | 0.1 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.1 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.1 | 1.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.1 | 0.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 0.8 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.1 | 0.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.1 | 2.1 | GO:0006811 | ion transport(GO:0006811) |
| 0.1 | 0.4 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 0.1 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 | 0.5 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 0.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.1 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 | 0.9 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.1 | 1.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
| 0.1 | 0.4 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 5.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.1 | 0.2 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.1 | 1.7 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 1.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 1.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.1 | 1.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 2.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.1 | 1.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 1.7 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 0.5 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 0.6 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.4 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 | 0.7 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.1 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.1 | 0.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 | 2.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.1 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 0.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.1 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.1 | 2.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 1.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 1.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 0.2 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.1 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 1.5 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
| 0.1 | 10.9 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.7 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 | 1.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 1.8 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 0.6 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.1 | 0.1 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.1 | 0.1 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.1 | 1.6 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 | 0.7 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.1 | 0.2 | GO:1903308 | regulation of chromatin modification(GO:1903308) |
| 0.1 | 1.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.1 | 2.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 | 3.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 0.9 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
| 0.1 | 4.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.1 | 0.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 0.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
| 0.1 | 0.2 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) response to glycoprotein(GO:1904587) |
| 0.1 | 0.1 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.1 | 0.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 | 1.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.1 | 1.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.1 | 1.6 | GO:0051775 | response to redox state(GO:0051775) |
| 0.1 | 0.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.1 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.3 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
| 0.1 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 0.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.1 | 0.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.2 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.1 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 | 3.4 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 1.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 0.4 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.1 | 0.1 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.1 | 0.2 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
| 0.1 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.1 | 0.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 | 0.8 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 0.4 | GO:0002741 | regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.1 | 0.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.1 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 1.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.9 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 2.1 | GO:0007268 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) |
| 0.1 | 0.7 | GO:0046697 | decidualization(GO:0046697) |
| 0.1 | 13.8 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.1 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 | 2.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 0.7 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.1 | 0.4 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
| 0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
| 0.1 | 0.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
| 0.1 | 0.4 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 | 0.3 | GO:0042551 | neuron maturation(GO:0042551) |
| 0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 | 0.4 | GO:0097480 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
| 0.1 | 0.2 | GO:1900005 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 | 4.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 | 0.2 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.1 | 0.1 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.1 | 0.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.1 | 0.2 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.1 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 | 0.1 | GO:0032355 | response to estradiol(GO:0032355) |
| 0.1 | 0.5 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 | 5.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.6 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
| 0.1 | 0.6 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.1 | 0.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 0.1 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 | 0.7 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.1 | 0.3 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.1 | 0.1 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 | 0.4 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.1 | 0.4 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.1 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.4 | GO:1904064 | positive regulation of cation transmembrane transport(GO:1904064) |
| 0.1 | 0.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 | 2.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
| 0.1 | 0.1 | GO:0032620 | interleukin-17 production(GO:0032620) |
| 0.1 | 0.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.6 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 2.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.2 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.1 | 0.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.1 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.1 | 3.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 13.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.1 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 1.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 | 0.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 | 0.2 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.1 | 3.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.1 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 4.3 | GO:0030203 | glycosaminoglycan metabolic process(GO:0030203) |
| 0.1 | 1.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 1.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 1.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.5 | GO:0070487 | monocyte aggregation(GO:0070487) |
| 0.1 | 0.4 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 1.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.1 | 1.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 0.5 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.1 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.5 | GO:0050777 | negative regulation of immune response(GO:0050777) |
| 0.1 | 0.1 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 | 6.5 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.1 | 0.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 0.4 | GO:0045117 | azole transport(GO:0045117) |
| 0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
| 0.1 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.1 | 0.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 0.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 | 0.7 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
| 0.1 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
| 0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 1.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.1 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 1.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 0.1 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
| 0.1 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.1 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.1 | 0.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.1 | 1.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 0.5 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.1 | 0.1 | GO:0032618 | interleukin-15 production(GO:0032618) |
| 0.1 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 | 0.2 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 1.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.1 | 0.1 | GO:0072594 | establishment of protein localization to organelle(GO:0072594) |
| 0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.1 | 0.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.1 | 0.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 0.2 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
| 0.1 | 0.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 | 0.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.1 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.1 | 0.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 0.2 | GO:0032288 | myelin assembly(GO:0032288) |
| 0.1 | 0.3 | GO:0072033 | renal vesicle formation(GO:0072033) |
| 0.1 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
| 0.1 | 2.2 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 0.1 | 0.4 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.1 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.0 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.0 | 0.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.0 | 0.1 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 | 0.4 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.0 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.1 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.0 | 0.0 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.0 | 0.0 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.0 | 0.0 | GO:0033555 | multicellular organismal response to stress(GO:0033555) |
| 0.0 | 1.1 | GO:0022604 | regulation of cell morphogenesis(GO:0022604) |
| 0.0 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 0.5 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.0 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 | 1.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 0.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
| 0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) left/right axis specification(GO:0070986) |
| 0.0 | 0.6 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
| 0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.0 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.1 | GO:1902224 | ketone body metabolic process(GO:1902224) |
| 0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
| 0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 | 0.1 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.0 | 0.0 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 0.0 | 0.2 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.0 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 0.1 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.0 | 2.5 | GO:0030073 | insulin secretion(GO:0030073) |
| 0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.0 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.0 | 0.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 | 0.0 | GO:0051188 | cofactor biosynthetic process(GO:0051188) |
| 0.0 | 0.1 | GO:0048854 | brain morphogenesis(GO:0048854) |
| 0.0 | 2.4 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.0 | 0.0 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.0 | 0.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
| 0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
| 0.0 | 2.1 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.0 | 0.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.0 | 0.1 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.1 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
| 0.0 | 0.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.0 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 | 0.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.4 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.1 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
| 0.0 | 0.8 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 1.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.0 | 0.0 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.0 | 0.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 | 3.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.0 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 0.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.0 | 1.4 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
| 0.0 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.1 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.0 | 0.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.1 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.0 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.0 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
| 0.0 | 1.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 1.4 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 0.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
| 0.0 | 0.0 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 | 0.0 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.2 | GO:0050821 | protein stabilization(GO:0050821) |
| 0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 | 0.0 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 | 0.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 | 0.1 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
| 0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
| 0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.0 | 0.3 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
| 0.0 | 0.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.3 | GO:0048839 | inner ear development(GO:0048839) |
| 0.0 | 0.0 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
| 0.0 | 0.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.0 | 0.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 0.0 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 | 0.0 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
| 0.0 | 0.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.0 | 0.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.0 | 1.2 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
| 0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 0.0 | 0.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.1 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
| 0.0 | 0.1 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
| 0.0 | 0.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.0 | 0.0 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
| 0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.0 | 0.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 | 0.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 12.6 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 2.5 | 22.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 2.4 | 7.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 2.1 | 10.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 2.0 | 5.9 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 2.0 | 25.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 1.8 | 18.2 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 1.8 | 1.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 1.7 | 3.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 1.6 | 4.9 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 1.6 | 6.5 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.5 | 4.6 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 1.5 | 6.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.5 | 4.6 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 1.4 | 26.1 | GO:0045179 | apical cortex(GO:0045179) |
| 1.4 | 7.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 1.4 | 4.2 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 1.3 | 7.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 1.3 | 24.1 | GO:0042627 | chylomicron(GO:0042627) |
| 1.2 | 1.2 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-3 complex(GO:0005608) |
| 1.2 | 3.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 1.2 | 14.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 1.1 | 43.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 1.1 | 3.4 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 1.1 | 6.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 1.1 | 6.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 1.0 | 8.2 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 1.0 | 4.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 1.0 | 2.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 1.0 | 6.1 | GO:1990742 | microvesicle(GO:1990742) |
| 1.0 | 5.0 | GO:0070701 | mucus layer(GO:0070701) |
| 1.0 | 16.9 | GO:0031045 | dense core granule(GO:0031045) |
| 1.0 | 56.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 1.0 | 15.4 | GO:0005883 | neurofilament(GO:0005883) |
| 1.0 | 39.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.9 | 27.9 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.9 | 23.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.9 | 0.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.9 | 6.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.9 | 6.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.9 | 20.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.8 | 2.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.8 | 2.5 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) postsynaptic endocytic zone membrane(GO:0098844) |
| 0.8 | 13.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.8 | 8.9 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.8 | 2.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.8 | 14.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.8 | 4.8 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.8 | 4.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.8 | 3.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.8 | 2.3 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.8 | 3.8 | GO:0044393 | microspike(GO:0044393) |
| 0.8 | 12.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.8 | 81.4 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.8 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.8 | 3.0 | GO:1990357 | terminal web(GO:1990357) |
| 0.7 | 2.9 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.7 | 3.6 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.7 | 12.9 | GO:0016342 | catenin complex(GO:0016342) |
| 0.7 | 9.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.7 | 2.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.7 | 2.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.7 | 10.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.7 | 2.0 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 0.7 | 22.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.7 | 1.4 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 0.7 | 3.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.7 | 12.5 | GO:0030673 | axolemma(GO:0030673) |
| 0.6 | 6.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.6 | 10.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.6 | 3.8 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.6 | 1.9 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.6 | 5.7 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.6 | 3.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.6 | 1.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.6 | 1.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.6 | 1.8 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.6 | 9.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.6 | 1.8 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.6 | 1.2 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.6 | 2.4 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.6 | 1.8 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.6 | 2.3 | GO:0043218 | compact myelin(GO:0043218) |
| 0.6 | 1.7 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 0.6 | 7.3 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.6 | 1.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.6 | 7.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.6 | 7.7 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.5 | 2.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.5 | 13.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.5 | 4.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.5 | 4.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.5 | 2.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.5 | 4.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.5 | 1.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.5 | 1.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.5 | 9.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.5 | 45.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.5 | 2.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.5 | 5.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.5 | 4.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.5 | 10.6 | GO:0036038 | MKS complex(GO:0036038) |
| 0.5 | 7.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.5 | 0.5 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.5 | 1.5 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.5 | 9.0 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.5 | 2.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.5 | 2.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.5 | 2.5 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.5 | 6.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.5 | 1.5 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.5 | 3.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.5 | 11.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.5 | 14.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.5 | 1.9 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.5 | 9.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.5 | 53.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.5 | 1.9 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.5 | 8.3 | GO:0042599 | lamellar body(GO:0042599) |
| 0.5 | 0.5 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.5 | 3.6 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.4 | 0.9 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.4 | 5.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.4 | 1.8 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.4 | 1.8 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.4 | 0.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.4 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 134.0 | GO:0098793 | presynapse(GO:0098793) |
| 0.4 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.4 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
| 0.4 | 32.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.4 | 2.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.4 | 13.0 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.4 | 1.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.4 | 6.6 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.4 | 10.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.4 | 1.2 | GO:0043219 | lateral loop(GO:0043219) |
| 0.4 | 1.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.4 | 0.8 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.4 | 1.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.4 | 0.4 | GO:0043235 | receptor complex(GO:0043235) |
| 0.4 | 14.7 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.4 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.4 | 20.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.4 | 1.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.4 | 0.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.4 | 14.1 | GO:0030057 | desmosome(GO:0030057) |
| 0.4 | 1.1 | GO:0001534 | radial spoke(GO:0001534) |
| 0.4 | 1.9 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.4 | 6.5 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.4 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.4 | 1.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.4 | 3.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.4 | 0.7 | GO:0030120 | vesicle coat(GO:0030120) |
| 0.4 | 1.9 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.4 | 38.3 | GO:0005902 | microvillus(GO:0005902) |
| 0.4 | 3.3 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.4 | 4.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 115.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.4 | 2.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.4 | 2.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.4 | 6.1 | GO:0097433 | dense body(GO:0097433) |
| 0.4 | 133.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.4 | 29.2 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.4 | 1.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.4 | 9.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 96.2 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.3 | 32.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.3 | 2.4 | GO:0089701 | U2AF(GO:0089701) |
| 0.3 | 1.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.3 | 1.4 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.3 | 2.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.3 | 2.0 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.3 | 3.3 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.3 | 2.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.3 | 1.3 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.3 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.3 | 55.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.3 | 10.3 | GO:0032420 | stereocilium(GO:0032420) |
| 0.3 | 12.1 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.3 | 4.1 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 0.9 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.3 | 9.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.3 | 0.9 | GO:0097182 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.3 | 1.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.3 | 3.7 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.3 | 1.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.3 | 5.8 | GO:0000145 | exocyst(GO:0000145) |
| 0.3 | 2.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.3 | 39.3 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.3 | 1.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.3 | 0.6 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.3 | 1.5 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.3 | 0.9 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.3 | 10.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.3 | 7.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.3 | 2.3 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.3 | 1.8 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.3 | 11.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.3 | 8.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.3 | 2.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.3 | 22.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.3 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.3 | 1.7 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.3 | 14.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.3 | 1.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.3 | 43.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.3 | 2.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.3 | 55.9 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.3 | 0.8 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 1.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.3 | 19.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.3 | 0.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.3 | 0.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.3 | 1.9 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.3 | 1.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.3 | 0.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
| 0.3 | 2.9 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.3 | 1.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.3 | 3.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.3 | 2.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.3 | 0.8 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.2 | 3.0 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 3.7 | GO:0030315 | T-tubule(GO:0030315) |
| 0.2 | 1.0 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 5.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 2.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.2 | 0.7 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.2 | 0.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.2 | 0.9 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 1.4 | GO:0070695 | FHF complex(GO:0070695) |
| 0.2 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.2 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.2 | 1.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 3.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.2 | 25.4 | GO:0070160 | occluding junction(GO:0070160) |
| 0.2 | 4.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.2 | 31.8 | GO:0030426 | growth cone(GO:0030426) |
| 0.2 | 7.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.2 | 1.1 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.2 | 1.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.2 | 1.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 0.9 | GO:0097196 | Shu complex(GO:0097196) |
| 0.2 | 1.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 0.9 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.2 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.2 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.2 | 14.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.2 | 1.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.2 | 4.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 2.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 1.7 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.2 | 2.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 0.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.2 | 23.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.2 | 5.4 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 0.4 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.2 | 7.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 2.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 3.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.2 | 3.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 1.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.2 | 0.6 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.2 | 2.7 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.2 | 3.5 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.2 | 0.7 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.2 | 6.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.2 | 11.1 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.2 | 58.9 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.2 | 0.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.2 | 190.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.2 | 1.6 | GO:0016589 | NURF complex(GO:0016589) |
| 0.2 | 127.4 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.2 | 1.2 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.2 | 1.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.2 | 0.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.2 | 10.9 | GO:0098858 | actin-based cell projection(GO:0098858) |
| 0.2 | 1.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 1.0 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 4.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 1.0 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 1.1 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.2 | 1.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 1.0 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 1.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 14.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.2 | 6.8 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 0.5 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.2 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 2.3 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 15.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 468.4 | GO:1903561 | extracellular vesicle(GO:1903561) |
| 0.1 | 3.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.4 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.1 | 0.6 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 4.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 1.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 2.4 | GO:0044297 | cell body(GO:0044297) |
| 0.1 | 0.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 0.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 0.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.1 | 545.2 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.1 | 2.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 1.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.1 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
| 0.1 | 0.4 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.1 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.1 | 14.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.1 | 0.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 0.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.1 | 7.1 | GO:0099568 | cytoplasmic region(GO:0099568) |
| 0.1 | 0.8 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.8 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 0.8 | GO:1990351 | transporter complex(GO:1990351) |
| 0.1 | 0.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 4.2 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 2.8 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 7.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 1.0 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 0.2 | GO:0036457 | keratohyalin granule(GO:0036457) |
| 0.1 | 2.7 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 12.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 2.6 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 2.2 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 35.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 2.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 1.8 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.3 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.1 | 0.3 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.1 | 0.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.1 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 6.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.1 | 45.7 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.7 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 1.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.3 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 3.3 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.2 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.0 | 0.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 0.1 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.0 | 0.5 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
| 0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.0 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.2 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.0 | 0.1 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.1 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.0 | 0.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.0 | 0.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.0 | 0.0 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.0 | 1.0 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 4.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.2 | 4.2 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 4.1 | 16.5 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 4.0 | 15.9 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 3.7 | 11.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 3.3 | 13.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 3.2 | 12.8 | GO:1904493 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
| 3.0 | 9.0 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 2.8 | 8.4 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 2.7 | 8.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 2.6 | 21.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 2.5 | 10.2 | GO:0008431 | vitamin E binding(GO:0008431) |
| 2.5 | 7.6 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 2.5 | 12.6 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 2.4 | 7.1 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 2.3 | 11.6 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 2.2 | 8.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 2.1 | 6.4 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 2.0 | 10.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 2.0 | 5.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 2.0 | 7.8 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 2.0 | 13.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 1.9 | 7.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 1.9 | 11.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 1.9 | 7.6 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 1.9 | 5.6 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 1.8 | 5.5 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 1.8 | 5.5 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 1.8 | 7.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 1.8 | 7.2 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.7 | 5.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 1.7 | 5.2 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 1.7 | 6.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 1.7 | 3.3 | GO:0016832 | fructose-bisphosphate aldolase activity(GO:0004332) aldehyde-lyase activity(GO:0016832) |
| 1.7 | 5.0 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 1.6 | 4.9 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 1.6 | 1.6 | GO:0050436 | microfibril binding(GO:0050436) |
| 1.6 | 19.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 1.6 | 4.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.6 | 6.3 | GO:0070704 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 1.5 | 13.8 | GO:0016717 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 1.5 | 4.6 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 1.4 | 8.7 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.4 | 4.3 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 1.4 | 27.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 1.4 | 12.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.4 | 4.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 1.4 | 7.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 1.4 | 7.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 1.4 | 5.6 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 1.4 | 11.2 | GO:0004359 | glutaminase activity(GO:0004359) |
| 1.4 | 4.2 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 1.4 | 23.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 1.3 | 5.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 1.3 | 18.9 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 1.3 | 1.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 1.3 | 7.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 1.3 | 7.9 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 1.3 | 3.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 1.3 | 6.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.3 | 1.3 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 1.3 | 7.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.3 | 5.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 1.2 | 3.7 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 1.2 | 5.0 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 1.2 | 5.0 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 1.2 | 5.0 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 1.2 | 12.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 1.2 | 23.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 1.2 | 8.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 1.2 | 10.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 1.2 | 4.8 | GO:0070404 | NADH binding(GO:0070404) |
| 1.2 | 3.6 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 1.2 | 25.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 1.2 | 4.8 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 1.2 | 4.7 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.2 | 5.8 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 1.2 | 5.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 1.2 | 4.6 | GO:0019862 | IgA binding(GO:0019862) |
| 1.2 | 3.5 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 1.2 | 6.9 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 1.1 | 5.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.1 | 4.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 1.1 | 16.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 1.1 | 3.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 1.1 | 1.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 1.1 | 4.4 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 1.1 | 4.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 1.1 | 2.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 1.1 | 4.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 1.1 | 5.4 | GO:0033265 | choline binding(GO:0033265) |
| 1.1 | 3.3 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 1.1 | 2.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 1.1 | 4.3 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 1.1 | 12.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 1.1 | 8.6 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 1.1 | 3.2 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 1.0 | 2.1 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
| 1.0 | 4.2 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 1.0 | 3.1 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 1.0 | 4.2 | GO:1990175 | EH domain binding(GO:1990175) |
| 1.0 | 4.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 1.0 | 3.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 1.0 | 2.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 1.0 | 5.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.0 | 6.1 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 1.0 | 2.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 1.0 | 8.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 1.0 | 7.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 1.0 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 1.0 | 3.0 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 1.0 | 14.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 1.0 | 3.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 1.0 | 16.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 1.0 | 1.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 1.0 | 3.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.0 | 8.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.9 | 11.4 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.9 | 4.7 | GO:0070905 | serine binding(GO:0070905) |
| 0.9 | 2.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.9 | 2.8 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.9 | 2.8 | GO:0070260 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 0.9 | 3.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.9 | 2.8 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.9 | 4.6 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.9 | 20.1 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.9 | 3.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.9 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.9 | 2.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.9 | 1.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.9 | 3.5 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.9 | 2.7 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.9 | 2.6 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.9 | 5.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.9 | 2.6 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.9 | 4.4 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.9 | 3.5 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.9 | 9.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.9 | 7.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.9 | 1.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.9 | 2.6 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.9 | 2.6 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.9 | 0.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.9 | 2.6 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.9 | 7.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.8 | 2.5 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
| 0.8 | 38.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.8 | 3.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.8 | 2.5 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.8 | 7.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.8 | 28.4 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.8 | 5.8 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.8 | 21.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 0.8 | 4.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.8 | 2.5 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.8 | 0.8 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.8 | 4.9 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.8 | 1.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.8 | 2.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.8 | 4.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.8 | 5.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.8 | 21.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.8 | 4.0 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.8 | 6.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.8 | 2.4 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.8 | 12.8 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.8 | 2.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.8 | 4.8 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.8 | 22.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.8 | 11.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.8 | 37.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.8 | 3.9 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.8 | 3.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.8 | 10.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.8 | 4.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.8 | 3.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.8 | 0.8 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.8 | 6.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.8 | 3.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.8 | 4.6 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.8 | 2.3 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.8 | 3.8 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.8 | 3.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.8 | 10.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.8 | 1.5 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.8 | 16.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.8 | 4.6 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.8 | 13.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.8 | 4.5 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.7 | 1.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.7 | 29.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.7 | 5.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.7 | 2.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.7 | 3.0 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.7 | 2.9 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.7 | 12.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.7 | 2.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.7 | 2.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.7 | 2.9 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.7 | 3.7 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.7 | 0.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.7 | 3.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.7 | 2.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.7 | 5.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.7 | 2.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.7 | 4.3 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.7 | 3.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.7 | 5.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.7 | 2.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.7 | 1.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.7 | 0.7 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.7 | 4.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.7 | 6.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.7 | 22.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.7 | 2.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.7 | 2.8 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.7 | 2.1 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.7 | 2.1 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 0.7 | 2.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.7 | 3.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.7 | 6.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.7 | 23.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.7 | 2.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.7 | 0.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 0.7 | 4.0 | GO:0052845 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.7 | 4.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.7 | 0.7 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.7 | 2.0 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.7 | 7.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.7 | 7.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.7 | 2.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.7 | 7.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.7 | 13.8 | GO:0008430 | selenium binding(GO:0008430) |
| 0.7 | 6.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.7 | 2.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.6 | 3.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.6 | 3.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.6 | 3.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.6 | 3.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.6 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.6 | 3.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.6 | 2.6 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.6 | 4.5 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.6 | 7.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 4.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.6 | 2.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.6 | 6.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.6 | 19.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.6 | 7.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.6 | 2.5 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
| 0.6 | 2.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.6 | 4.4 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.6 | 11.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.6 | 3.1 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.6 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.6 | 1.9 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
| 0.6 | 13.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.6 | 1.8 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.6 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.6 | 2.4 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.6 | 3.0 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.6 | 4.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.6 | 3.0 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.6 | 3.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.6 | 4.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.6 | 17.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.6 | 15.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.6 | 3.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.6 | 3.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.6 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.6 | 4.7 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.6 | 2.9 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.6 | 1.8 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.6 | 2.3 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.6 | 2.3 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.6 | 2.3 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.6 | 8.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.6 | 8.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.6 | 0.6 | GO:0051380 | norepinephrine binding(GO:0051380) |
| 0.6 | 2.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 0.6 | 2.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.6 | 0.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.6 | 1.7 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.6 | 5.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.6 | 19.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.6 | 3.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.6 | 13.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.6 | 16.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.6 | 2.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.6 | 6.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.6 | 2.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.5 | 1.1 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.5 | 1.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.5 | 1.6 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.5 | 22.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.5 | 2.2 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.5 | 2.2 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.5 | 12.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.5 | 2.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.5 | 3.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.5 | 4.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.5 | 7.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.5 | 8.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.5 | 4.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.5 | 2.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.5 | 0.5 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.5 | 6.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.5 | 4.7 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.5 | 6.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.5 | 1.0 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.5 | 0.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.5 | 6.2 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.5 | 4.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.5 | 1.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.5 | 12.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.5 | 52.4 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.5 | 2.6 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.5 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.5 | 10.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.5 | 2.0 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.5 | 2.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.5 | 10.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.5 | 2.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.5 | 3.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.5 | 5.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.5 | 9.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.5 | 7.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.5 | 4.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.5 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.5 | 1.5 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.5 | 2.0 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.5 | 0.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.5 | 15.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.5 | 1.5 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.5 | 6.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.5 | 2.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.5 | 2.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.5 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.5 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.5 | 1.4 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.5 | 2.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.5 | 1.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.5 | 2.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.5 | 5.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.5 | 1.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.5 | 4.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.5 | 0.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.5 | 0.5 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 0.5 | 1.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.5 | 2.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.5 | 2.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.5 | 3.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.5 | 7.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.5 | 20.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.5 | 18.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.5 | 3.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.5 | 4.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.4 | 2.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.4 | 0.9 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.4 | 1.3 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.4 | 2.7 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
| 0.4 | 4.0 | GO:0042835 | BRE binding(GO:0042835) |
| 0.4 | 15.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.4 | 4.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.4 | 21.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.4 | 2.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.4 | 1.3 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.4 | 5.7 | GO:0031386 | protein tag(GO:0031386) |
| 0.4 | 1.8 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.4 | 1.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.4 | 0.9 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.4 | 15.8 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
| 0.4 | 0.9 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.4 | 2.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.4 | 3.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.4 | 10.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.4 | 6.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.4 | 0.9 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.4 | 3.0 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.4 | 3.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.4 | 2.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.4 | 0.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.4 | 2.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.4 | 3.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.4 | 4.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.4 | 12.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.4 | 1.7 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 0.4 | 17.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.4 | 2.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.4 | 6.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.4 | 3.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.4 | 3.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.4 | 0.8 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.4 | 3.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.4 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.4 | 2.5 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.4 | 1.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.4 | 2.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.4 | 2.9 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.4 | 1.2 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.4 | 2.0 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.4 | 2.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.4 | 2.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.4 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.4 | 9.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.4 | 4.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.4 | 2.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.4 | 6.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.4 | 1.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.4 | 1.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.4 | 3.5 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.4 | 59.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.4 | 3.9 | GO:0033764 | steroid dehydrogenase activity(GO:0016229) steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
| 0.4 | 2.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.4 | 0.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.4 | 1.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.4 | 3.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.4 | 1.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.4 | 1.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.4 | 3.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.4 | 10.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.4 | 1.2 | GO:0035671 | enone reductase activity(GO:0035671) |
| 0.4 | 2.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.4 | 25.7 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.4 | 1.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.4 | 3.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.4 | 1.1 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.4 | 9.6 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
| 0.4 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.4 | 19.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.4 | 8.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.4 | 3.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.4 | 2.3 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.4 | 3.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
| 0.4 | 0.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.4 | 2.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.4 | 1.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.4 | 1.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.4 | 12.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.4 | 10.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.4 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.4 | 4.8 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.4 | 1.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.4 | 2.2 | GO:0046790 | virion binding(GO:0046790) |
| 0.4 | 2.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.4 | 1.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.4 | 1.1 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.4 | 2.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.4 | 5.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.4 | 6.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.4 | 1.4 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
| 0.4 | 1.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.4 | 1.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.4 | 1.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.4 | 1.8 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.4 | 0.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.4 | 1.1 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.4 | 6.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.4 | 4.6 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.4 | 10.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.4 | 1.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.4 | 8.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.3 | 2.8 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.3 | 1.0 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.3 | 16.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.3 | 2.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.3 | 1.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
| 0.3 | 1.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.3 | 1.0 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.3 | 1.0 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.3 | 1.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.3 | 2.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.3 | 2.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 1.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.3 | 3.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.3 | 4.4 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
| 0.3 | 3.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 2.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 0.3 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.3 | 2.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.3 | 1.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.3 | 1.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.3 | 6.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 2.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.3 | 16.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.3 | 2.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.3 | 2.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.3 | 1.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.3 | 1.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.3 | 13.5 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 7.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.3 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.3 | 2.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.3 | 5.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.3 | 2.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.3 | 6.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 5.7 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.3 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.3 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.3 | 6.3 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.3 | 1.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 0.3 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.3 | 11.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.3 | 1.2 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.3 | 4.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.3 | 4.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.3 | 4.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.3 | 2.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.3 | 15.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.3 | 1.2 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.3 | 2.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.3 | 2.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.3 | 3.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.3 | 1.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.3 | 2.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.3 | 1.8 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.3 | 6.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.3 | 2.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.3 | 2.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.3 | 2.3 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.3 | 1.2 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.3 | 0.9 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.3 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.3 | 16.8 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.3 | 2.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.3 | 0.6 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.3 | 0.9 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
| 0.3 | 15.6 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.3 | 1.7 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.3 | 0.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.3 | 7.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.3 | 2.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.3 | 5.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 0.8 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.3 | 1.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.3 | 2.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.3 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.3 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.3 | 11.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.3 | 0.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.3 | 2.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.3 | 0.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.3 | 2.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.3 | 1.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.3 | 3.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.3 | 2.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.3 | 1.9 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.3 | 2.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 2.4 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
| 0.3 | 0.3 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 0.3 | 1.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.3 | 0.8 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.3 | 17.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.3 | 8.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 4.5 | GO:0019864 | IgG binding(GO:0019864) |
| 0.3 | 4.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.3 | 1.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.3 | 1.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.3 | 2.3 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.3 | 3.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.3 | 0.8 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.3 | 1.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.3 | 0.8 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.3 | 0.8 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.3 | 0.8 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.3 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.3 | 1.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.3 | 0.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.3 | 5.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.3 | 9.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.3 | 6.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.2 | 0.7 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.2 | 0.7 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.2 | 0.7 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.2 | 0.7 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.2 | 2.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 3.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.2 | 15.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.2 | 2.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.2 | 6.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.2 | 4.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 0.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.2 | 0.7 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.2 | 1.0 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.2 | 0.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.2 | 4.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.2 | 4.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.2 | 2.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 0.7 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 5.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.2 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.2 | 0.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 2.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.2 | 4.2 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.2 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.2 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.2 | 3.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 9.1 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.2 | 34.2 | GO:0005525 | GTP binding(GO:0005525) |
| 0.2 | 17.1 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.2 | 11.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 12.3 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.2 | 0.2 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 0.2 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 5.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 1.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.2 | 3.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.2 | 0.9 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.2 | 5.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.2 | 8.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 6.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.2 | 2.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.2 | 4.0 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.2 | 0.7 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.2 | 2.9 | GO:0015250 | water channel activity(GO:0015250) |
| 0.2 | 0.9 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.2 | 2.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.2 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.2 | 1.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.2 | 2.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 2.6 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
| 0.2 | 1.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.2 | 0.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.2 | 1.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.2 | 3.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.2 | 1.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.2 | 1.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.2 | 1.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.2 | 1.5 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 1.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 2.3 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.2 | 2.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 0.8 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.2 | 1.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.2 | 1.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.2 | 0.6 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.2 | 2.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 2.3 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.2 | 0.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.2 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.2 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.2 | 2.1 | GO:0070990 | snRNP binding(GO:0070990) |
| 0.2 | 3.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.2 | 0.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.2 | 0.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.2 | 15.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.2 | 2.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.2 | 0.6 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
| 0.2 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.2 | 0.6 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.2 | 4.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.2 | 0.8 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.2 | 4.8 | GO:0001848 | complement binding(GO:0001848) |
| 0.2 | 0.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.2 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 11.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.2 | 0.6 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.2 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 0.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
| 0.2 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.2 | 2.6 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 0.8 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.2 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.2 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.2 | 2.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.2 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.2 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.2 | 3.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.2 | 0.6 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.2 | 0.6 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.2 | 0.6 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.2 | 1.7 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.2 | 1.1 | GO:0005113 | patched binding(GO:0005113) |
| 0.2 | 0.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.2 | 0.6 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.2 | 0.7 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.2 | 0.7 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.2 | 1.8 | GO:0010851 | cyclase regulator activity(GO:0010851) |
| 0.2 | 3.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.2 | 0.4 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 0.5 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.2 | 3.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 8.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.2 | 0.7 | GO:0005497 | androgen binding(GO:0005497) |
| 0.2 | 1.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.2 | 0.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.2 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 3.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 1.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.2 | 0.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.2 | 0.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.2 | 1.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.2 | 3.4 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 2.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 3.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.2 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.2 | 0.9 | GO:0002046 | opsin binding(GO:0002046) |
| 0.2 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.2 | 0.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.2 | 4.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 0.7 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.2 | 2.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.2 | 8.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 1.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.2 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.2 | 1.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.2 | 0.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.2 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
| 0.2 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.2 | 1.0 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.2 | 0.7 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 4.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 1.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.2 | 0.8 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 0.2 | 3.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 7.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.2 | 0.7 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.2 | 2.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.2 | 1.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 0.5 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.2 | 1.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.2 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 1.0 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.2 | 0.5 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.2 | 4.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 0.5 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.2 | 0.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 3.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.2 | 25.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 3.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.2 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 1.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 0.6 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.2 | 2.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.2 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.2 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.2 | 1.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.2 | 1.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.2 | 2.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 6.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 0.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.2 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 0.2 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.2 | 0.8 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.2 | 2.9 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.2 | 0.6 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.2 | 8.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 1.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.2 | 1.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.2 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.2 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 2.7 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.1 | 0.4 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.1 | 0.4 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.1 | 1.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 0.9 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 9.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 3.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.9 | GO:0004904 | interferon receptor activity(GO:0004904) |
| 0.1 | 1.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.4 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 0.7 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.1 | 2.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.1 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 1.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 3.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 8.9 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
| 0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.1 | 0.7 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.1 | 1.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 4.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 3.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 25.9 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 47.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.1 | 0.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 0.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 2.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.1 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
| 0.1 | 0.1 | GO:0097604 | temperature-gated ion channel activity(GO:0097603) temperature-gated cation channel activity(GO:0097604) |
| 0.1 | 4.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.3 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 1.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 4.8 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.1 | 2.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 2.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.1 | 2.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.1 | 4.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 0.9 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.1 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 0.6 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.1 | 4.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 3.1 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.1 | 0.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.1 | 0.1 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.1 | 1.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 8.1 | GO:0016597 | amino acid binding(GO:0016597) |
| 0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 7.2 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 3.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 0.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 5.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.1 | 1.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.4 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.1 | 1.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 1.8 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
| 0.1 | 1.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.1 | 0.2 | GO:0001847 | opsonin receptor activity(GO:0001847) complement component C5a receptor activity(GO:0004878) |
| 0.1 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.1 | 0.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.1 | 1.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 1.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.3 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.1 | 3.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 3.5 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 1.8 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 1.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 1.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.1 | 2.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
| 0.1 | 14.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 6.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.1 | 1.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 0.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.1 | 0.9 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.1 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.6 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 2.7 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.1 | 1.0 | GO:0015293 | symporter activity(GO:0015293) |
| 0.1 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 1.6 | GO:0001948 | glycoprotein binding(GO:0001948) |
| 0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 3.6 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.1 | 0.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 2.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.1 | 0.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 0.2 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
| 0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.1 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 0.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.1 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 0.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.1 | 7.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.1 | 0.2 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.1 | 0.9 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.1 | 0.4 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
| 0.1 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 1.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.1 | 0.9 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 0.2 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.2 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 1.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.1 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 0.1 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.1 | 2.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 8.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.5 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 2.9 | GO:0051287 | NAD binding(GO:0051287) |
| 0.1 | 13.4 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 3.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.1 | 0.3 | GO:0019955 | cytokine binding(GO:0019955) |
| 0.1 | 40.8 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.1 | 11.9 | GO:0005543 | phospholipid binding(GO:0005543) |
| 0.1 | 5.6 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.1 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.1 | 0.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.1 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.0 | 1.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 0.1 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.0 | 0.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.0 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.4 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.0 | 0.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.0 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.0 | 0.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.0 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 1.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 9.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 0.0 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.0 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 1.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.0 | 0.2 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.0 | 0.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.0 | 3.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.0 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 1.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.1 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.0 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.0 | 0.0 | GO:0010181 | FMN binding(GO:0010181) |
| 0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.0 | 0.2 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.0 | 1.1 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.0 | 0.0 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.0 | 0.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.1 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.0 | 0.1 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.0 | 0.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 0.0 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
| 0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.0 | 0.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.0 | 0.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 24.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.5 | 29.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.5 | 16.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.5 | 15.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.5 | 8.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.4 | 35.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.4 | 0.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.4 | 24.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.4 | 24.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.4 | 38.5 | PID FGF PATHWAY | FGF signaling pathway |
| 0.4 | 1.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.4 | 0.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.4 | 36.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.4 | 14.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.4 | 29.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.4 | 12.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.3 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.3 | 13.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.3 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.3 | 11.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 14.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.3 | 22.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 11.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.3 | 4.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.3 | 24.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.3 | 24.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.3 | 2.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 30.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.2 | 2.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 2.6 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 7.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.2 | 6.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.2 | 2.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 8.1 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 3.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 4.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 4.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.2 | 1.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.2 | 7.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.2 | 1.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 3.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 4.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.2 | 50.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 11.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.2 | 8.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.2 | 2.7 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 4.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.2 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 3.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 2.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 1.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 3.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 1.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 4.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 3.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 17.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 5.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 1.4 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 5.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 4.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 6.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 1.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 8.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 2.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 2.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 9.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 4.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 4.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 37.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 8.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 1.4 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 3.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 1.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 1.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 3.3 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 6.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 5.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 1.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 1.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 5.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 2.5 | 2.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 1.3 | 59.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 1.3 | 37.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 1.2 | 45.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 1.2 | 17.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 1.1 | 20.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 1.1 | 3.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 1.1 | 16.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.1 | 3.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 1.0 | 30.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 1.0 | 47.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.8 | 8.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.8 | 15.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.8 | 16.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.8 | 23.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.7 | 19.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.7 | 34.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.7 | 4.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.7 | 48.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.7 | 18.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.7 | 19.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.7 | 9.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.7 | 16.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.6 | 10.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.6 | 19.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.6 | 29.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.6 | 15.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.6 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.6 | 4.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.6 | 22.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.6 | 14.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.6 | 23.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.6 | 12.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.6 | 12.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.6 | 13.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.6 | 27.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.6 | 16.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.5 | 12.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.5 | 7.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.5 | 7.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.5 | 19.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.5 | 16.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.5 | 12.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.5 | 2.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.5 | 29.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.5 | 14.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.5 | 3.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
| 0.5 | 9.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.5 | 8.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.5 | 24.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.5 | 16.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.4 | 21.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.4 | 16.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.4 | 14.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.4 | 13.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.4 | 12.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.4 | 14.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.4 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.4 | 6.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.4 | 10.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.4 | 6.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.4 | 8.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.4 | 29.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.4 | 8.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.4 | 4.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.4 | 95.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.4 | 17.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.4 | 21.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.4 | 6.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.4 | 39.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.4 | 3.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.4 | 21.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.4 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.4 | 7.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.4 | 10.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.4 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.4 | 7.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.4 | 9.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 0.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.3 | 6.8 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.3 | 1.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.3 | 5.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.3 | 1.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.3 | 9.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.3 | 12.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.3 | 6.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.3 | 0.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.3 | 7.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.3 | 8.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.3 | 10.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.3 | 4.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.3 | 53.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.3 | 4.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.3 | 18.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.3 | 6.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.3 | 6.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.3 | 2.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.3 | 5.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.3 | 8.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.3 | 6.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.3 | 4.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.3 | 10.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.3 | 15.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.3 | 7.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.3 | 7.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.3 | 3.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 4.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.2 | 3.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 5.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 8.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 2.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.2 | 4.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.2 | 5.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 8.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 1.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.2 | 3.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 5.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 4.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.2 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 1.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 0.2 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
| 0.2 | 23.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 4.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.2 | 11.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 0.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.2 | 13.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 3.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.2 | 5.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 4.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 22.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.2 | 4.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.2 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 1.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 39.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.2 | 2.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 1.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.2 | 1.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.2 | 15.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.2 | 3.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 2.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.2 | 1.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.2 | 8.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 9.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.2 | 1.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.2 | 0.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.2 | 8.1 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 8.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 5.0 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.1 | 1.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 1.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 4.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 1.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 0.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.1 | 5.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 2.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 1.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 6.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.1 | 0.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 2.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 2.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 3.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 8.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 5.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 1.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 6.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 6.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 2.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 1.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 1.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 3.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 5.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 6.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.1 | 12.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 7.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 14.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 3.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 2.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 3.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 0.3 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 0.1 | 1.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 10.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.1 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 4.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 1.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 1.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 0.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.1 | 4.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.0 | 3.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |